Liver cancer ranks the sixth in cancer incidence and the second in tumor related mortality
worldwide, with over half of the new cases and deaths occur in China. Because of difficulties …

HCC (hepatocellular carcinoma) is the second leading cause of cancer deaths worldwide,
with several etiologic causes, mostly inflammation-associated. Different inflammatory …

Liver cancer is an extraordinarily heterogeneous malignant disease among the tumors that
have so far been identified. Hepatocellular carcinoma (HCC) arises most frequently in the …

Emerging evidence suggests that altered components and posttranslational modifications of
proteins in the extracellular matrix (ECM) may both initiate and drive disease progression …

As the metabolic and detoxification center of the body, the liver is closely involved in many
critical physiological processes, such as metabolism, immunity, digestion, storage of liver …

Background Gut microbiota (GM) of patients with liver cancer is disordered, and syet no
study reported the GM distribution of liver cirrhosis‐induced HCC (LC‐HCC) and nonliver …

Hepatocellular carcinoma (HCC) is one of the most prevalent and fatal digestive tumors.
Treatment for this disease has been constraint by heterogeneity of this group of tumors …

Liver cancer or hepatocellular carcinoma (HCC) is leading cause of cancer-related
mortalities globally. The therapeutic approaches for chronic liver diseases-associated liver …

Chronic infection with hepatitis viruses represents the major causative factor for end-stage
liver diseases, including liver cirrhosis and primary liver cancer (hepatocellular carcinoma …

Background The onset of hepatocellular carcinoma (HCC) ranked fifth malignancies all over
the world. Increasing evidences showed that the distribution of HCC was related to the …